NewsRx

Search our medical news database

Infectious Disease Therapy

GSQ1530 could be effective against drug-resistant microbes

Published in Drug Week, October 18th, 2002

by Michael Greer, senior medical writer - Researchers in the United States say that a novel antimicrobial agent shows promise against drug-resistant pathogens.

"GSQ1530 is a compound derived from a newly identified class of antibiotics referred to as heteroaromatic polycyclic (HARP) antibiotics," explained Yigong Ge and colleagues working at Genesoft, Inc. in South San Francisco and Herndon, Virginia-based Focus Technologies.

GSQ1530 was highly effective against a wide range of Gram-positive microbes in vitro, including methicillin-resistant Staphylococcus aureus (MRSA), Ge and coauthors reported.

The researchers evaluated...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook